Related Experiment Video
Updated: Jun 6, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Engineered Reactive Oxygen Species (ROS)-Responsive Artificial H+/Cl- Ion Channels for Targeted Cancer Treatment
Chunyan Jia1,2, Daoxin Luo1,2, Jin Zhou1
1State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, School of Pharmaceutical Sciences, Xiamen University Xiamen, Fujian 361102, China.
Abstract:
Reactive oxygen species (ROS)-responsive ion channels regulate the ion flow across the membranes in response to alterations in the cellular redox state, playing a crucial role in cellular adaptation to oxidative stress. Despite their significance, replicating ROS-responsive functionality in artificial ion channels remains elusive. In this study, we introduce a novel class of artificial H+/Cl- ion channels activatable by elevated ROS levels in cancer cells. ROS-induced decaging of the phenylboronate group triggers the rapid release of the channel-forming units, leading to self-assembly of the H-bonded cascades facilitating the synergistic transport of H+ and Cl- ions, with H+/Cl- ion transport selectivity of 7.7. Upon activation, ROS-C-Cl exhibits significant apoptotic activity against human breast cancer cells, achieving an IC50 of 2.8 μM, comparable to that of paclitaxel. Exploiting the intrinsic oxidative microenvironment of cancer cells, along with the enhanced oxidative stress arising from H+/Cl- co-transport, ROS-C-Cl demonstrates exceptional selectivity in targeting cancer cells with a selectivity index of 10.2 over normal breast cells, outperforming that of paclitaxel by 19.4 folds.
Insights
Researchers developed novel artificial ion channels that activate in response to reactive oxygen species (ROS) in cancer cells. These ROS-responsive channels show potent and selective cancer cell apoptosis, offering a new therapeutic strategy.
Area of Science:
- Biochemistry and Molecular Biology
- Materials Science
- Nanotechnology
Background:
- Reactive oxygen species (ROS)-responsive ion channels are vital for cellular adaptation to oxidative stress.
- Artificial replication of ROS-responsive ion channel functionality remains a significant challenge.
- Cancer cells exhibit altered redox states and elevated ROS levels.
Purpose of the Study:
- To design and synthesize a novel class of artificial ion channels responsive to elevated ROS levels.
- To investigate the self-assembly mechanism and ion transport properties of these artificial channels.
- To evaluate the therapeutic potential and selectivity of the ROS-responsive channels against cancer cells.
Main Methods:
- Development of artificial H+/Cl- ion channels activated by ROS-induced decaging.
- Investigation of channel self-assembly into H-bonded cascades.
- Assessment of H+/Cl- ion transport selectivity and apoptotic activity in human breast cancer cells.
Main Results:
- A novel artificial H+/Cl- ion channel (ROS-C-Cl) was successfully synthesized and activated by ROS.
- ROS-C-Cl self-assembles into functional cascades with an H+/Cl- ion transport selectivity of 7.7.
- ROS-C-Cl demonstrated significant apoptotic activity against human breast cancer cells (IC50 = 2.8 μM) with high selectivity (SI = 10.2).
Conclusions:
- Artificial ROS-responsive H+/Cl- ion channels can be effectively designed and synthesized.
- ROS-C-Cl exhibits potent and selective anti-cancer activity by exploiting the tumor's oxidative microenvironment.
- This novel approach offers a promising strategy for targeted cancer therapy.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...